Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chorionic gonadotropin.

D P Goldstein

    Cancer
    |July 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Biochemical markers like chorionic gonadotropin (CG) are revolutionizing oncology. Measuring CG aids in diagnosing, monitoring, and detecting recurrence of various cancers, including choriocarcinoma and nontrophoblastic neoplasms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development and validation of a clinical prediction-score model for distant metastases in major salivary gland carcinoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.

    Current oncology (Toronto, Ont.)·2019
    Same author

    HPV Status Improves Classification of Head and Neck Gray Zone Cancers.

    Journal of dental research·2019
    Same author

    A dvances in understanding of molar pregnancy.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    Therapeutic protocols for FIGO Stages of GTD.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy.

    Current oncology (Toronto, Ont.)·2017
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Oncology
    • Biochemistry
    • Tumor marker research

    Background:

    • Biochemical tags serve as crucial cell markers in modern oncology for diagnosis and treatment monitoring.
    • Chorionic gonadotropin (CG) measurement was the first reliable marker for choriocarcinoma and gestational trophoblastic disease.
    • CG production rate approximates functional neoplastic tissue, normally produced only by syncytiotrophoblasts.

    Purpose of the Study:

    • To highlight the utility of biochemical markers in cancer management.
    • To discuss the established role of CG in choriocarcinoma and related diseases.
    • To explore the emerging potential of CG as a marker in nontrophoblastic neoplasms.

    Main Methods:

    • Review of established diagnostic and monitoring protocols using CG.

    Related Experiment Videos

  • Analysis of CG production rates in relation to neoplastic tissue.
  • Investigation into the production of CG by nontrophoblastic malignant neoplasms.

    • Main Results:

    • CG measurement is a reliable tool for diagnosing and monitoring choriocarcinoma and gestational trophoblastic disease.
    • CG levels correlate with the amount of functional neoplastic tissue.
    • Nontrophoblastic cancers are increasingly found to produce CG, suggesting broader applicability.

    Conclusions:

    • CG measurement is a vital tool in managing specific gynecological and testicular cancers.
    • The discovery of CG production in nontrophoblastic tumors opens new avenues for cancer monitoring.
    • Further research is needed to fully understand the potential of CG as a universal tumor marker.